Cherry Tree Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.4M Buy
1,518
+2
+0.1% +$2.03K 0.3% 64
2025
Q4
$1.63M Sell
1,516
-11
-0.7% -$10.5K 0.34% 59
2025
Q3
$1.17M Hold
1,527
0.26% 65
2025
Q2
$1.19M Sell
1,527
-13
-0.8% -$10.1K 0.28% 64
2025
Q1
$1.27M Buy
1,540
+9
+0.6% +$7.49K 0.31% 61
2024
Q4
$1.18M Hold
1,531
0.29% 61
2024
Q3
$1.36M Hold
1,531
0.32% 59
2024
Q2
$1.39M Buy
1,531
+10
+0.7% +$8K 0.35% 58
2024
Q1
$1.18M Hold
1,521
0.3% 60
2023
Q4
$887K Sell
1,521
-32
-2% -$18.7K 0.24% 69
2023
Q3
$834K Hold
1,553
0.24% 62
2023
Q2
$728K Buy
+1,553
New +$651K 0.21% 65

Other funds holding LLY

Cherry Tree Wealth Management's LLY Position: Q1 2026 in Review

Cherry Tree Wealth Management increased its Eli Lilly (LLY) stake by 0.13% in Q1 2026, buying an estimated $2.03K and bringing the position to 1,518 shares worth $1.4M. The position accounts for 0.3% of the portfolio, ranked #64.

Cherry Tree Wealth Management first reported a position in LLY in Q2 2023 and has held it in 12 quarters since. The position peaked at $1.63M in Q4 2025. 4,382 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Cherry Tree Wealth Management held 1,518 shares of Eli Lilly worth $1.4M as of Q1 2026.
  • Cherry Tree Wealth Management bought 2 Eli Lilly shares in Q1 2026, an estimated $2.03K.
  • Eli Lilly made up 0.3% of Cherry Tree Wealth Management's portfolio in Q1 2026, its #64 holding.
  • Cherry Tree Wealth Management first reported a position in Eli Lilly in Q2 2023 and has held it in 12 quarters since.
  • Cherry Tree Wealth Management's Eli Lilly position peaked at $1.63M in Q4 2025.
  • 4,382 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Cherry Tree Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.